Literature DB >> 12473470

Source, carriers, and management of a Serratia marcescens outbreak on a pulmonary unit.

E R van der Vorm1, C Woldring-Zwaan.   

Abstract

An outbreak of Serratia marcescens was seen on a pulmonary ward from September 1999 until September 2000. During this period, there were two distinct clusters of S. marcescens isolation. In the first episode, September-October 1999, S. marcescens isolates with the same resistance pattern were isolated in 10 patients. PFGE (pulsed-field gel electrophoresis) following digestion with SpeI confirmed that these isolates were identical. After an initial decline in the number of isolates, the incidence rose again in March 2000. The resistance pattern of these isolates differed from that in 1999. PFGE showed that most of the isolates in 2000 were identical and had replaced the previous strain (strain 1). In the second episode, January-August 2000, 26 patients were colonized with the subsequent strain (strain 2). Three of these patients had serious clinical problems due to S. marcescens, two had bacteraemia and one empyema. In September 2000, strain 2 was also detected in stock solutions for inhalation therapy. After discontinuation of the use of stock solutions and emphasizing hygienic measures, the outbreak resolved. The majority (68%) of the patients positive for S. marcescens suffered from COPD (chronic obstructive pulmonary disease). PFGE results suggest that several COPD patients were carriers of the same strain of S. marcescens for a prolonged time. Re-admission of these patients could have lead to re-introduction of the epidemic strains. Copyright 2002 The Hospital Infection Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473470     DOI: 10.1053/jhin.2002.1313

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  The prevalence of bacterial contamination of surgical cold sterile solutions from community companion animal veterinary practices in southern Ontario.

Authors:  Colleen P Murphy; J Scott Weese; Richard J Reid-Smith; Scott A McEwen
Journal:  Can Vet J       Date:  2010-06       Impact factor: 1.008

2.  Requirement for Serratia marcescens cytolysin in a murine model of hemorrhagic pneumonia.

Authors:  Norberto González-Juarbe; Chris A Mares; Cecilia A Hinojosa; Jorge L Medina; Angelene Cantwell; Peter H Dube; Carlos J Orihuela; Molly A Bergman
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

Review 3.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Single-channel characterization of the chitooligosaccharide transporter chitoporin (SmChiP) from the opportunistic pathogen Serratia marcescens.

Authors:  H Sasimali M Soysa; Sawitree Kumsaoad; Rawiporn Amornloetwattana; Takeshi Watanabe; Wipa Suginta
Journal:  J Biol Chem       Date:  2022-09-13       Impact factor: 5.486

5.  Human pathogen shown to cause disease in the threatened eklhorn coral Acropora palmata.

Authors:  Kathryn Patterson Sutherland; Sameera Shaban; Jessica L Joyner; James W Porter; Erin K Lipp
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

6.  An Outbreak of Serratia marcescens in a Moroccan Neonatal Intensive Care Unit.

Authors:  Abdellatif Daoudi; Fatiha Benaoui; Nadia El Idrissi Slitine; Nabila Soraa; Fadl Mrabih Rabou Maoulainine
Journal:  Adv Med       Date:  2018-11-01

7.  A Case of Serratia marcescens Endocarditis in a Nonintravenous Drug-Using Male Patient and Review of Literature.

Authors:  Achilleas Nikolakopoulos; Nikolaos Koutsogiannis; Panagiota Xaplanteri; Charalambos Gogos; Fevronia Kolonitsiou; Alexandra Lekkou
Journal:  Case Rep Infect Dis       Date:  2019-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.